BCS Class 3 Biowaivers and Transporter Considerations 31. March 2016 Presentation – James E. Polli University of Maryland Background Prior human in vivo studies Recent series of in vivo human studies of 14 common excipients Potential transporter (or enzyme or nuclear receptor) x excipient interaction concern Conclusions James E. Polli [email protected] October 27, 2015 355.pdf Adobe Acrobat Document 1.7 MB Download Share
31. March 2016 Presentation – James E. Polli University of Maryland Background Prior human in vivo studies Recent series of in vivo human studies of 14 common excipients Potential transporter (or enzyme or nuclear receptor) x excipient interaction concern Conclusions James E. Polli [email protected] October 27, 2015 355.pdf Adobe Acrobat Document 1.7 MB Download